Feasibility and benefit of decompressive percutaneous endoscopic gastrostomy (dPEG) in advanced cancer patients with malignant bowel obstruction
Endoscopy International Open · 01.11.2024 · 12 (11) · E1411-E1416
DOI: 10.1055/a-2458-9919 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 01.11.2024. Verfasst von Julia Wanzl und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, University Hospital Augsburg, Augsburg, Germany. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background and study aims Bowel obstruction is a common complication in advanced cancer patients. Patients are restricted in quality of life (QOL) due to nausea, vomiting, or abdominal pain. Prospective data on the feasibility and benefit of decompressive percutaneous endoscopic gastrostomy (dPEG) are scarce. Patients and methods Patients suffering from symptomatic bowel obstruction due to advanced cancer were included prospectively in a single-center study when other treatments to eliminate the obstruction were impossible. Patients were given a questionnaire the day before dPEG (d-1) and, if the procedure was successful, the day after (d+1) and 14 days after the procedure (d14). Furthermore, lifetime after dPEG was assessed. Results 53 patients were included. dPEG was technically feasible in 34 of 53 (64.2%). Significant improvement could be shown for nausea and vomiting when comparing d-1 to d+1 (nausea (P = 0.002), vomiting (P < 0.001)) and when comparing d-1 to d14 (P = 0.021 and P = 0.003, respectively). Comparing d+1 to d14, there was no further improvement. QOL improved significantly from 8.1 (mean) on d-1 to 5.9 (mean) on d+1 (P < 0.001). Median survival after successful dPEG was 27 days (range 2–353). Conclusions dPEG is an effective method for quickly relieve symptoms of malignant bowel obstruction in advanced cancer patients. However, the technical success rate is limited and needs to be improved. Prospective studies comparing endoscopic and computed tomography-guided procedures are needed to avoid unsuccessful procedures in patients with advanced cancer and limited life expectancy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, University Hospital Augsburg, Augsburg, Germany.
- Department of Gastroenterology, University of Augsburg, Augsburg, Germany.
- Department of Digital Medicine, University Hospital Augsburg, Augsburg, Germany.
- Department of Palliative Medicine, University of Augsburg, Augsburg, Germany.
Zitieren
APA
Wanzl, J., Höfer, S., Schwamberger, T., Tadic, V., Muzalyova, A., Hainsch-Müller, I., Aulmann, C., Messmann, H., & Probst, A. (2024). Feasibility and benefit of decompressive percutaneous endoscopic gastrostomy (dPEG) in advanced cancer patients with malignant bowel obstruction. Endoscopy International Open, 12(11), E1411-E1416. https://doi.org/10.1055/a-2458-9919
Vancouver
Wanzl J, Höfer S, Schwamberger T, Tadic V, Muzalyova A, Hainsch-Müller I, et al. Feasibility and benefit of decompressive percutaneous endoscopic gastrostomy (dPEG) in advanced cancer patients with malignant bowel obstruction. Endoscopy International Open. 2024;12(11):E1411-E1416. doi:10.1055/a-2458-9919
BibTeX
@article{Wanzl2024,
author = {Wanzl, Julia and Höfer, Susanne and Schwamberger, Tanja and Tadic, Vidan and Muzalyova, Anna and Hainsch-Müller, Irmtraut and Aulmann, Christoph and Messmann, Helmut and Probst, Andreas},
title = {Feasibility and benefit of decompressive percutaneous endoscopic gastrostomy (dPEG) in advanced cancer patients with malignant bowel obstruction},
journal = {Endoscopy International Open},
year = {2024},
volume = {12},
number = {11},
pages = {E1411--E1416},
doi = {10.1055/a-2458-9919}
}
EUVIMED